Claudius Conrad - Concepedia

Author

Claudius Conrad

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A. G. Mammoser, C Conrad, C. A. Conrad, C. Conrad, Claudius CONRAD, Claudius Conrad, Claudius Conrad MD, PhD, Conrad, Claudius, Fabrice Colin, Frédéric Marchal

273

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Harvard University Massachusetts General Hospital St. Elizabeth's Medical Center Tufts University

About

Claudius Conrad is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, surgery, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	49	2.7K
2	Health Sciences	5	5	216
3	Natural Sciences	1	1	39
4	Nursing	1	1	16
5	Public Health	1	1	20

Claudius Conrad

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene Dawang Zhou, Claudius Conrad, Fan Xia, Cancer Cell Tumor BiologyHepatologyMedicineLiver PhysiologyPathology	2009	927
<i>STAT3</i> Plays a Critical Role in <i>KRAS</i> -Induced Pancreatic Tumorigenesis Ryan B. Corcoran, Gianmarco Contino, Vikram Deshpande, Cancer Research	2011	408
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors James R. Howe, Nipun B. Merchant, Claudius Conrad, Pancreas	2019	368
Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival Yoshihiro Mise, Thomas A. Aloia, Kristoffer W. Brudvik, Annals of Surgery	2015	304
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases Kristoffer W. Brudvik, Robert Jones, Felice Giuliante, Annals of Surgery	2017	266
Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis Stephan Huber, Christiane J. Bruns, G. Schmid, Kidney International ImmunologyAutophagyLymphatic SystemRapamycin Impedes LymphangiogenesisLymphatic Disease	2007	203
Return to intended oncologic treatment (RIOT): A novel metric for evaluating the quality of oncosurgical therapy for malignancy Thomas A. Aloia, Giuseppe Zimmitti, Claudius Conrad, Journal of Surgical Oncology	2014	196
Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo Claudius Conrad, Ralf Huss, Stephan Huber, Circulation	2009	165
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases Yun Shin Chun, Guillaume Passot, Suguru Yamashita, Annals of Surgery	2017	163
RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases Kristoffer W. Brudvik, Yoshihiro Mise, Michael Chung, Annals of Surgical Oncology Patients Undergoing ResectionSurgical OncologyHepatologyColorectal Liver MetastasesNarrower Resection Margins	2016	153

Page 1